Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Smart report aims to match breast cancer patients with best drugs

NCT ID NCT07590583

First seen May 16, 2026 · Last updated May 23, 2026 · Updated 2 times

Summary

This early-stage study tests whether a special report, created from a patient's tumor tissue, can help doctors choose the most effective treatments for advanced hormone receptor-positive breast cancer. The report looks at the cancer's biology to suggest which drugs might work and which might not. About 20 participants will receive this report, and researchers will measure how quickly it can be produced and how useful it is for guiding treatment decisions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE IV BREAST CANCER AJCC V8 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91010, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • City of Hope at Irvine Lennar

    Irvine, California, 92618, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.